The Leukemia & Lymphoma Society (LLS) advocates public policy positions that accelerate progress toward cures for leukemia, Hodgkin and non-Hodgkin lymphoma and myeloma.
The aim of LLS's advocacy program is to improve the quality of life of those with blood cancer, their friends and families. The following links will provide information on LLS's legislative priorities aimed at accomplishing that goal. The Second Session of the 111th Congress Legislative Agenda for The Leukemia & Lymphoma Society Department of Defense (DoD) Blood Cancer Research Program Increase Cancer Research Funding at the National Institutes of Health (NIH) and National Cancer Institute (NCI) The Cures Acceleration Network (CAN) Access to Clinical Trials Blood Cancer Awareness Month Resolution- September 2010 Pediatric Cancer Survivorship Legislation Comprehensive Cancer Care Funding ALERT Cancer Legislation the Centers for Disease Control and Prevention (CDC) Blood Cancer Education Program Health Care Reform Issue Briefs
